GW Pharma (GWPH) Posts Q1 Loss of 9c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
GW Pharmaceuticals plc Reports Second Quarter and Half-Year 2016 Financial Results and Operational Progress
May 5, 2016 7:02 AM EDT- Positive Phase 3 Epidiolex pivotal trial in Dravet syndrome -- Initial LGS Phase 3 pivotal data expected in June -- Conference call today at 9:00 a.m. EDT, 2:00 p.m. BST -
LONDON, May 05, 2016 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH) (AIM: GWP) (AIM:GW) (the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced financial results for the second quarter and half-year... More
The Cannabis Market Reaches New Heights
May 4, 2016 2:35 PM EDTNEW YORK, May 4, 2016 /PRNewswire/ --
It is a rare opportunity when a market that is potentially worth hundreds of billions of dollars is virtually untouched by large companies. While the number of states where the growth and sales of Cannabis products remains limited, the majority of the population in the United States approves the end of federal marijuana prohibition nationwide. For now, in states where cannabis is a legitimate and legal product, sales are through the roof. Â
A recent report by New Frontier and ArcView Market Research has revealed some very impressive numbers. Sales of... More
